• Subscriptions
  • Contact
Documenta Haematologica - Revista Romana de Hematologie
  • About Us
  • Editorial Board
  • Current Issue
  • Archive
    • 2023 Volume 1
      • Issue 1
      • Issue 2
      • Issue 3
      • Issue 4
    • 2024 Volume 2
      • Issue 1
      • Issue 2
      • Issue 3
      • Issue 4
    • 2025 Volume 3
      • 2025, Volume 3, Issue 1
      • 2025, Volume 3, Issue 2
      • 2025, Volume 3, Issue 3
      • 2025, Volume 3, Issue 4
    • 2026 Volume 4
      • 2026, Volume 4, Issue 1
  • Editorial Process & Peer Review
  • Ethics and Rights
  • How To Submit
Select Page

The Benefit of Brentuximab Vedotin and Checkpoint Inhibitors in Relapsed/Refractory Hodgkin Lymphoma: A Single-Center Retrospective Study

by Catalin | Jun 25, 2025 | 2025 vol. 3 issue 2

The Benefit of Brentuximab Vedotin and Checkpoint Inhibitors in Relapsed/Refractory Hodgkin Lymphoma: A Single-Center Retrospective Study Diana-Marina FORTOES, Elena NICORICI, Cosmin MINCIUNA Andrei CIANGA, Ramona TIMOFTE, Amalia TITIEANU, Elena DOLACHI-PELIN, Ion...

Clinical Diversity and Treatment Outcomes in IgM Monoclonal Gammopathy Associated with Cold Agglutinin Disease and Cryoglobulinemia: A Single Center Study

by Catalin | Jun 25, 2025 | 2025 vol. 3 issue 2

Clinical Diversity and Treatment Outcomes in IgM Monoclonal Gammopathy Associated with Cold Agglutinin Disease and Cryoglobulinemia: A Single Center Study Larisa ZIDARU, Sinziana BARBU, Ruxandra DRAGHICI, Sebastian Nicolae TIMOTEI, Daniel CORIU, Sorina Nicoleta...

Caplacizumab in the Treatment of Patients with Recurrent Thrombotic Thrombocytopenic Purpura (TTP)

by Catalin | Mar 28, 2025 | 2025 vol. 3 issue 1

Caplacizumab in the Treatment of Patients with Recurrent Thrombotic Thrombocytopenic Purpura (TTP) Mihaela-Sabrina HERDEA, Adela-Sara IONESCU, Oana PATRINOIU, Mihaela ANDREESCU We report two cases of recurrent thrombotic thrombocytopenic purpura, both patients without...

Evaluation of the Benefit of Ropeginterferon Treatment in Patients with Polycythemia Vera

by Catalin | Mar 28, 2025 | 2025 vol. 3 issue 1

Evaluation of the Benefit of Ropeginterferon Treatment in Patients with Polycythemia Vera Diana GRASU, Viola Maria POPOV, Mirela VOICU, Mihaela POPESCU, Oana PATRINOIU, Felicia MIHAI, Geanina OFITERU, Meilin OMER, Mihaela ANDREESCU Results: Twenty-three patients (15...

Is Quality of Life Better in Hemophilia Patients with or Without Prophylactic Treatment? Using Haemo-SYM to Answer the Question

by Catalin | Mar 28, 2025 | 2025 vol. 3 issue 1

Is Quality of Life Better in Hemophilia Patients with or Without Prophylactic Treatment? Using Haemo-SYM to Answer the Question Catalina GURAN, Mieta-Gabriela HATEGAN, Dacian Nicolae OROS, Despina CALAMAR-POPOVICI, Marioara IONITA HORTENSIA, Claudiu IONITA, Florica...
« Older Entries
Next Entries »

Recent Posts

  • Challenges in the management of DLBCL in Pregnancy – A Case Report
  • Whispers from the Liver: A Hidden Case of CD10+ High-Grade B-cell Lymphoma
  • A Retrospective Study of Sickle Cell Disease Patients’ Clinical and Laboratory Data as Predictors of Disease Morbidity and Mortality in a Single Center (KFHU), Saudi Arabia
  • Prognostic Factors in Polycythemia Vera
  • Real-World Outcomes and Morphological Patterns of Aggressive Non-Hodgkin Lymphoma in Moldova: A Five-Year Retrospective Cohort Study

Recent Comments

  1. A WordPress Commenter on Hello world!

Copyright © 2025 | Edited by Romanian Society of Hematology